Death Risks Seen In U.S. Asthma Drugs

June 8, 2006 |

1 min read

Several popular U.S. bronchodilator drugs used to treat asthma can be potentially dangerous or fatal, a Stanford University analysis of 19 studies shows.

GlaxoSmithKline

MORE ON THIS TOPIC

Genetown

The Best Way to Answer Salary Interview Questions

June 11, 2024

·

4 min read

·

Lorenzo Soliman

Pictured: Man holding tablet computer with scienti

Job Trends

Life Sciences R&D, Manufacturing Talent Becoming More Difficult to Find: Report

June 6, 2024

·

3 min read

·

Pictured: FDA sign at its office in Washington, DC/iStock, JHVEPhoto

Policy

FDA Again Rejects Supernus Drug-Device Combo for Parkinson’s Disease

April 8, 2024

·

2 min read

·

Pictured: 3d illustration of hepatitis B viruses i

Drug Development

Altimmune Axes Hepatitis B Program After Phase II Failure, Focuses on Obesity and MASH

March 28, 2024

·

1 min read

·